跳至主要内容
临床试验/IRCT20201128049520N1
IRCT20201128049520N1尚未招募2 期

The effect of alcoholic extract of the olive leaf on clinical and Laboratory outcomes of patients with Covid-19

Khoram-Abad University of Medical Sciences0 个研究点目标入组 129 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
129

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
All

入选标准

  • All patients with Quid-19 based on standard diagnostic test (positive PCR test, CT scan of lung) approved by infectious disease specialist
  • Age range is 18 to 70 years
  • Have a level of consciousness of 15 according to the Glasgow standard

排除标准

  • Take oleopurine supplements 3 months before the study
  • Use of mechanical ventilation equipment
  • Existence of underlying respiratory diseases such as COPD, asthma
  • Taking anti-hypertensive, anti-platelet and anti-diabetic drugs
  • Pregnancy and lactation
  • Immune system deficiency or the use of immunosuppressive drugs
  • Malignancies
  • Presence of heart, kidney, liver, blood pressure, diabetes and corticosteroid disorders
  • Reluctance to continue cooperation
  • The patient is discharged earlier than the completion of the treatment period
  • Hypotension (mean arterial pressure less than 70 mm Hg)
  • Hypoglycemia (blood sugar less than 75 mg / dL)
  • Existence of allergies to drugs before and during the study
  • Lack of proper use of drugs
  • The need for therapeutic interventions other than the usual therapeutic interventions during research such as the need for dialysis, angioplasty and ...
  • Participate in other research that in any way affects the results of the research

研究者

发起方
Khoram-Abad University of Medical Sciences

相似试验